Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Recruiting
Observational Study
Coronary Artery Disease
Arrhythmias, Cardiac
Heart Valve Diseases
Aortic Dissection
Heart Neoplasms
Myocarditis
Hypertension
Cardiomyopathies
Structural Heart Disease
Ischemic Cerebrovascular Disease
Hemorrhagic Cerebrovascular Disease
Brain Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25,000 (estimated)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study inte…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who are regularly visited and followed up in the appropriate patient; department.
* All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:
* coronary artery disease group;
* arrhythmia group;
* heart valve d…
Contacts